Home Cancer Risk

Cancer Risk

Study Shows Single Dose of Human Papillomavirus Vaccine May Be Effective...

Peter Hofland, Ph.D -

For the First Time Double-Digit Survival Rates Reported in Pancreatic Cancer

Danielle Garcia -

Excessive and Binge Drinking Surprisingly Common Among Cancer Survivors

Peter Hofland, Ph.D -
Blood test

Study Shows Circulating Tumor DNA to be Predictive of Disease Progression...

Peter Hofland, Ph.D -

Residual Cancer Burden After Neoadjuvant Chemotherapy can be a Predictor of...

Danielle Garcia -
Attendees during the San Antonio Breast Cancer Symposium being held at the Henry B. Gonzalez Convention Center in San Antonio, TX. This year is the 42nd Anniversary of the meeting where over 7,500 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Photo courtesy © 2019 AACR/SABCS Todd Buchanan

SABCS 2019: Women at Elevated Risk of Breast Cancer May Benefit...

Peter Hofland, Ph.D -
General Views during at the American Society of Hematology 61th Annual Meeting at the Orange County Convention Center. Photo Courtesy © 2019 ASH/Danny Morton.

Addressing Disparities in Cancer: Factors Influencing Care, Access and Outcomes

Peter Hofland, Ph.D -
Speakers and attendees during Poster Session 1 at the American Society of Hematology 61th Annual Meeting at the Orange County Convention Center, Friday December 6, 2019. Photo Courtesy American Society of Hematology © 2019 ASH/Nick Agro

ASH 2019: Real-World Data of Apixaban in Venous Thromboembolism Patients with...

Peter Hofland, Ph.D -
Human kidney cross section. Photo courtesy: 2019 Fotolia

Tivozanib Improved PFS and was better Tolerated Compared with Sorafenib in...

Peter Hofland, Ph.D -

Enfortumab Vedotin + Pembrolizumab to be Evaluated in Metastatic Bladder Cancer

Peter Hofland, Ph.D -
123...7Page 1 of 7

LATEST

© 2020 Sunvalley Communication, LLC. All Rights Reserved.